Oncolytic herpes simplex viruses designed for targeted treatment of EGFR-bearing tumors.
Ingusci S, Hall BL, Cohen JB, Glorioso JC
Mol Ther Oncol. 2024 Jan 10;32(1):200761. doi: 10.1016/j.omton.2024.200761. eCollection 2024 Mar 21.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.